New call-to-action
New call-to-action
New call-to-action

Foundation for Prader-Willi Blog | Research (38)

Categories

Potential for a future prenatal therapy for autism

A recent publication in Science raises a number of interesting questions regarding the potential for prenatal and perinatal (newborn) therapies in the prevention and treatment of autism spectrum disorder (ASD). This type of treatment would be a decad...
March 27, 2014 Read More

Topics: Research

The gut-brain connection: bacteria naturally carried in the gut may influence brain chemistry and behavior

Those with PWS often battle a variety of gastro-intestinal (GI) issues. Beyond general GI function and quality of life, there is a growing field of research exploring how GI composition and health is intricately connected to other systems in the body...
March 27, 2014 Read More

Topics: Research

An Improved Model of PWS: Generous Donation Allows Development of an Improved Rat Model

While the genetic engineering of mouse models has allowed scientists to successfully understand and develop new therapies for many genetic diseases, the PWS mouse models generated so far have not fully mimicked the complexity of human PWS, slowing th...
February 15, 2014 Read More

Topics: Research

Clinical Trials 2014 What You Need to Know - Webinar Summary

Over 450 excited parents and community members registered for the Clinical Trials Webinar January 19th. Theresa Strong and Jennifer Miller outlined an overview of the drug development process, discussed what you can expect when you participate in a c...
February 14, 2014 Read More

Topics: Research

Zafgen's Research into Weight Loss Drug, Beloranib, Looks Promising

Zafgen announced in November results of a completed Phase 2 study of their obesity drug, Beloranib, in severely obese patients (non-pws). Findings from the study demonstrated significant weight loss in 147 obese individuals over a 12 weeks of treatme...
February 13, 2014 Read More

Topics: Research

Long Term GH Therapy Improved Body Composition

Recent research out of Italy, reported in the Journal of Clinical Endocrinology and Metabolism, highlights the potential benefits of long-term growth hormone (GH) therapy in adults with PWS. The study, involving 15 obese adults with PWS treated with ...
February 12, 2014 Read More

Topics: Research

Clinical Trials In Our Community: Oxtyocin, Here We Come!

By Emma Roth and Lauren Schwartz-Roth, FPWR Board Member Lauren Roth and her daughter, Emma, share their experience of participating in the Oxytocin Clinical Trial at Vanderbilt University. Join this duo through their journey and learn more about the...
February 11, 2014 Read More

Topics: Research

The Top Ten Reasons to Take One SMALL Step in 2014 !

Recently we asked members of our One SMALL Step facebook page to share their reason for hosting a One SMALL Step event. Here are their top ten reasons. Hosting an event is like teaching a school lesson....the one that often learns the most is the tea...
February 10, 2014 Read More

Topics: Research

Are You Ready For an Exciting Year?

2014 is starting with a BANG! Several new PWS clinical trials will be beginning around the country will be evaluating potential therapies for PWS for children and adults with PWS. The active involvement of our community will be critical to seeing the...
January 2, 2014 Read More

Topics: Research

About FPWR

The Foundation for Prader-Willi Research (federal tax id 31-1763110) is a nonprofit corporation with federal tax exempt status as a public charity under section 501(c)(3).

4star120x60

NORD_MembershipLogo_Platinum_2021

excellence-in-giving-logo

Main Menu

Our Mission

The mission of FPWR is to eliminate the challenges of Prader-Willi syndrome through the advancement of research and therapeutic development.

Contact Us

Foundation for Prader-Willi Research
Phone: 888-322-5487
Email: info@fpwr.org

FPWR
440 N Barranca Ave #3620
Covina, CA 91723

Copyright © 2020. All Rights Reserved. Terms of Use. Privacy Policy. Copyright Infringement Policy. Disclosure Statement.